ORPHA — Orphazyme A/S Income Statement
0.000.00%
Last trade - 00:00
- DKK30.36m
- DKK16.39m
- 23
- 11
- 36
- 11
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 336 | 609 | 83.5 | 41.2 | 27 |
Operating Profit | -336 | -609 | -83.5 | -41.2 | -27 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -343 | -635 | -83.4 | -41.1 | -26 |
Provision for Income Taxes | |||||
Net Income After Taxes | -337 | -633 | -78.5 | -38.3 | -26 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -337 | -633 | -627 | 35.1 | -26 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -337 | -633 | -627 | 35.1 | -26 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16,888 | -22,324 | -2,248 | -1,086 | -738 |
Dividends per Share |